SPR Therapeutics receives $2.9 million grant from the National Institutes of Health

Story excerpt provided by Crain’s Cleveland Business.

Written by Scott Suttell.

Medical device company SPR Therapeutics of Cleveland said it received a $2.9 million Small Business Innovation Research (SBIR) grant from the National Institutes of Health to support the collection of clinical data required to commercialize its Smartpatch peripheral nerve stimulation system for treatment of post-stroke shoulder pain.

“We are very pleased to have received this grant following the rigorous and competitive review process established by the National Institutes of Health,” said Maria Bennett, president and CEO of SPR Therapeutics, in a news release. “These funds will help us accelerate enrollment in our ongoing study and position us to advance this promising technology to the final stages of U.S. regulatory review as quickly as possible.”

Click here to read the complete article.

Originally published May 14, 2014.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: